Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited is one of India‚Äôs leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are…
What Dr. files
- Others57
- Investor Meet32
- Updates25
- Important18
- Dividend/Bonus18
- Board Meeting14
Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
Dr. Lal Ventures, a subsidiary, completed its 30% stake subscription in Neuome Technologies. Neuome is now an associate company, expanding Dr. Lal PathLabs' strategic reach.
Dr Lal PathLabs' wholly-owned Dubai subsidiary incorporated a new step-down subsidiary, Dr Lal PathLabs Indomed LLC, in Tashkent, Uzbekistan. This expands its diagnostic services, with the subsidiary subscribing to 70% of the new entity's share capital at face value.
Dr. Lal Path Labs Ltd. has informed the Exchange regarding Allotment of 211050 Shares.
Dr. Lal PathLabs delivered a strong Q1 FY27. Revenue soared 19.1% YoY to Rs. 798 Cr, marking the highest quarterly growth in four years, with patient volumes up 8.2%. EBITDA grew 28.7% to Rs. 247 Cr (31% margin), while PAT increased 27.2% to Rs. 170 Cr. An interim dividend of...